Alternative vaccination against equine botulism (BoNT/C)

Equine Veterinary Journal

Volumn 39, Issue 6, 2007, Pages 516-520

  Frey, J ^a   Eberle, S ^a   Stahl, C ^a   Mazuet, C ^b   Popoff, M ^b   Schatzmann, E ^a   Gerber, V ^a   Dungu, B ^c   Straub, R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSTITUT PASTEUR   (France)

^c Onderstepoort Biological Products   (South Africa)

Author keywords

Botulism; Hc BoNT C; Horse; Mouse protection assay; Vaccine

Indexed keywords

EQUIDAE;

BACTERIAL VACCINE; BACTERIUM ANTIBODY; BOTULINUM TOXIN; BOTULINUM TOXIN TYPE C; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOASSAY; BIOSYNTHESIS; BLOOD; BOTULISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSE; HORSE DISEASE; IMMUNIZATION; IMMUNOLOGY; MALE; MOUSE; SERODIAGNOSIS; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BIOLOGICAL ASSAY; BLOTTING, WESTERN; BOTULINUM TOXINS; BOTULISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSE DISEASES; HORSES; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; MALE; MICE; NEUTRALIZATION TESTS; VACCINES, SYNTHETIC;

EID: 38449111020     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516407X236550     Document Type: Article

References (29)

1. Anon (1998) Botulism in the United States, 1899-1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Centers for Disease Control and Prevention.
2. Arnon, S.S., Schlechter, R., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., Swerdlow, D.L. and Tonat, K. (2001) Botulinum toxin as a biological weapon. J. Am. med. Ass. 285, 1059-1070.
3. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1999) Current Protocols in Molecular Biology 5, John Wiley & Sons, Inc., New York.
4. Boles, J., West, M., Montgomery, V., Tammariello, R., Pitt, M.L., Gibbs, P., Smith, L. and LeClaire, R.D. (2006) Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey. Toxicon 47, 877-884.
5. Breidenbach, M.A. and Brunger, A.T. (2005) New insights into clostridial neurotoxin-SNARE interactions. Trends mol. Med. 11, 377-381.
6. Byrne, M.P. and Smith, L.A. (2000) Development of vaccines for prevention of botulism. Biochimie 82, 955-966.
7. Clayton, M.A., Clayton, J.M., Brown, D.R. and Middlebrook, J.L. (1995) Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infect. Immun. 63, 2738-2742.
8. Dürre, P. (2004) Sporulation and its regulation in clostridia. In: Clostridium. Proceedings of the Meeting 'Food microbiology and sporulation of the genus Clostridium', Eds: C. Duchesnes, J. Mainil, M. Peck and P.E. Granum, Presses de la Faculté de Médecine Vétérinaire de l'Université de Liège, Liège. pp 71-75.
9. Eberle, S. (2007) Vaccination against Clostridium botulinum type C in Horses using Recombinant Peptides of the C'-terminal half of Hc BoNT/CD and BoNT/C Toxoid: Active Immunity and Clinical Side Effects. PhD Thesis, Bern.
10. Fairweather, N.F., Lyness, V.A. and Maskell, D.J. (1987) Immunization of mice against tetanus with fragments of tetanus toxin synthesized In: Escherichia coli. Infect. Immun. 55, 2541-2545.
11. Galey, F.D. (2001) Botulism in the horse. Vet. Clin. N. Am: Equine Pract. 17, 579-588.
12. Gerber, V., Frey, J. and Straub, R. (2006) Equine botulism and acute pasture myodystrophy: new soil borne emerging diseases in Switzerland? Schweiz. Arch. Tierheilk. 148, 553-559.
13. Göschel, H., Wolfarth, K., Frevert, J., Dengler, R. and Bigalke, H. (1997) Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies - therapeutic consequences. Exp. Neurol. 147, 96-102.
14. Harlow, E. and Lane, D. (1988) Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
15. Hunter, L.C. and Poxton, I.R. (2001) Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)? Equine vet. J. 33, 547-553.
16. Jansen, B.C., Knoetze, P.C. and Visser, F. (1976) The antibody response of cattle to Clostridium botulinum Types C and D toxoids. Onderstepoort J. vet. Res. 43, 165-174.
17. Lindström, M. and Korkeala, H. (2006) Laboratory diagnostics of botulism. Clin. Microbiol. Rev. 19, 298-314.
18. Mason, J.H., Steyn, H.P. and Bisschop, J.H.R. (1938) The immunization of bovines against lamsiekte. J. S. Afr. vet. Med. Ass. 9, 65-70.
19. Minton, N.P. (1995) Molecular genetics of clostridial neurotoxins. Curr. Top. Microbiol. Immunol. 195, 161-194.
20. Popoff, M.R. (1996) Entérotoxines bactériennes: structure, mode d'action et approche vaccinale. Revue Méd. Vét. 147, 425-438.
21. Popoff, M.R. (2003) Molecular biology of clostridial neurotoxins. In: Protein toxins of the Genus Clostridium and Vaccination. Proceedings of the Meeting, Eds: C. Duchesnes, J. Mainil, M. Popoff and R. Titball, Presses de la Faculté de Médecine Vétérinaire de l'Université de Liège, Liège. pp 25-44.
22. Rennels, M.B., Deloria, M.A., Pichichero, M.E., Englund, J.A., Anderson, E.L., Steinhoff, M.C., Decker, M.D. and Edwards, K.M. (2002) Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 20, S44-S47.
23. Schiavo, G., Matteoli, M. and Montecucco, C. (2000) Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717-766.
24. Siegel, L.S. (1988) Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay. J. clin. Microbiol. 26, 2351-2356.
25. Siegel, L.S. (1989) Evaluation of neutralizing antibodies to Type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid. J. clin. Microbiol. 27, 1906-1908.
26. Steinman, A., Kachtan, I., Levi, O. and Shpigel, N.Y. (2007) Seroprevalence of antibotulinum neurotoxin type C antibodies in horses in Israel. Equine vet. J. 39, 232-235.
27. Tavallaie, M., Chenal, A., Gillet, D., Pereira, Y., Manich, M., Gibert, M., Raffestin, S., Popoff, M.R. and Marvaud, J.C. (2004) Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett. 572, 299-306.
28. Tsukamoto, K., Kohda, T., Mukamoto, M., Takeuchi, K., Ihara, H., Saito, M. and Kozaki, S. (2005) Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. biol. Chem. 280, 35164-35171.
29. Whitwell, K.E., Harris, P. and Farrington, P.G. (1988) Atypical myoglobinuria: an acute myopathy in grazing horses. Equine vet. J. 20, 357-363.